The shadow of generic competition has long loomed above copyright’s famous drug, Sildenafil, raising questions about the future of similar pharmaceutical portfolios. While first times saw impressive gains, the patent expiration has opened the door for discounted substitutes, potentially diminishing revenue and presenting a genuine danger for shar